Tuesday, November 19, 2024
HomeIndustriesHealthcare

Healthcare

Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof-of-Concept

Avenge Bio, Inc., a biotechnology company developing the LOCOcyte immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, ...

Translational Research Describes an Epigenetic Approach for Regulating Fear-Memory

EpiVario, Inc., an emerging biotech company developing novel therapeutics for memory-related psychiatric disorders, highlighted preclinical research findings that could lead to a treatment approach...

Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the...

Spear Bio’s NAB-Sure Test Kit Aids Analysis of COVID-19 Immune Response

Pharmaceutical drug developers and healthcare researchers need innovative tools to understand COVID-19 immune response and validate vaccines and therapeutics critical to managing the pandemic....

Bioretec’s Activapin Bioresorbable Implant Provides Good Alternative Treatment

A recently published clinical study confirms the benefits of using fully bioresorbable ActivaPin implant together with bioabsorbable suture, for the tension band wire treatment...
0FansLike
0FollowersFollow
spot_img

Hot Topics